Seeking Alpha

BrainStorm's (BCLI.OB -2%) NurOwn adult stem cell therapy for treating Lou Gehrig's Disease...

BrainStorm's (BCLI.OB -2%) NurOwn adult stem cell therapy for treating Lou Gehrig's Disease brought about "improvement in many of the patients involved" in a small Phase I/II trial. Stem cells derived from patients' own bone marrow were treated with NurOwn before being transplanted back into the patients.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs